Table 2.
Pathway | Size | NES | P value | FDR |
---|---|---|---|---|
Cortisol synthesis and secretion | 64 | 0.50 | < 0.001 | 0.16 |
Adherens junction | 71 | 0.49 | < 0.001 | 0.097 |
Notch signaling pathway | 59 | 0.48 | < 0.001 | 0.083 |
Autophagy | 32 | 0.47 | < 0.001 | 0.085 |
Growth hormone synthesis, secretion and action | 118 | 0.46 | < 0.001 | 0.087 |
ERBB signaling pathway | 85 | 0.46 | < 0.001 | 0.075 |
Snare interactions in vesicular transport | 33 | 0.45 | 5.52e-3 | 0.075 |
Lysine degradation | 63 | 0.43 | < 0.001 | 0.10 |
Ovarian steroidogenesis | 50 | 0.43 | < 0.001 | 0.093 |
Insulin secretion | 84 | 0.43 | < 0.001 | 0.089 |
Alpha-linolenic acid metabolism | 24 | 0.42 | 0.0175 | 0.086 |
GNRH signaling pathway | 92 | 0.41 | < 0.001 | 0.10 |
Prolactin signaling pathway | 69 | 0.41 | < 0.001 | 0.094 |
Inositol phosphate metabolism | 73 | 0.41 | < 0.001 | 0.091 |
Chronic myeloid leukemia | 76 | 0.41 | < 0.001 | 0.087 |
Aldosterone synthesis and secretion | 97 | 0.41 | < 0.001 | 0.082 |
Phosphatidylinositol signaling system | 96 | 0.40 | < 0.001 | 0.092 |
Hedgehog signaling pathway | 56 | 0.40 | < 0.001 | 0.087 |
Endometrial cancer | 58 | 0.40 | < 0.001 | 0.089 |
Acute myeloid leukemia | 67 | 0.40 | < 0.001 | 0.086 |
Size represents the number of genes enriched in the corresponding pathway
NES Normalized enrichment score, FDR False discovery rate